Pharmacology of manipulating lean body mass

Patricio V Sepulveda, Ernest D Bush, Keith Baar

Research output: Contribution to journalArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Dysfunction and wasting of skeletal muscle as a consequence of illness decreases the length and quality of life. Currently, there are few, if any, effective treatments available to address these conditions. Hence, the existence of this unmet medical need has fuelled large scientific efforts. Fortunately, these efforts have revealed many of the underlying mechanisms adversely affecting skeletal muscle health. With increased understanding have come breakthrough disease-specific and broad spectrum interventions, some progressing through clinical development. This review focuses its attention on the role of antagonistic process regulating skeletal muscle mass before branching into prospective promising therapeutic targets and interventions. Special attentions is given to therapies in development against cancer cachexia and Duchenne Muscular Dystrophy before closing remarks on design and conceptualization of future therapies are presented to the reader.
Original languageEnglish
Pages (from-to)1 - 13
Number of pages13
JournalClinical and Experimental Pharmacology and Physiology
Volume42
Issue number1
DOIs
Publication statusPublished - 2015

Cite this